| 1 |
29372665 | DNA methylation of the Oct4A enhancers in embryonal carcinoma cells after etoposide treatment is associated with alternative splicing and altered pluripotency in reversibly senescent cells. | 2018 |
2 |
| 2 |
26625199 | Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1. | 2016 Jan 12 |
2 |
| 3 |
26102294 | Role of stress-activated OCT4A in the cell fate decisions of embryonal carcinoma cells treated with etoposide. | 2015 |
3 |
| 4 |
26506264 | p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia. | 2015 |
4 |
| 5 |
23287532 | DNA damage causes TP53-dependent coupling of self-renewal and senescence pathways in embryonal carcinoma cells. | 2013 Feb 1 |
1 |
| 6 |
23457546 | EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells. | 2013 |
2 |
| 7 |
23272236 | Sensitive detection and monitoring of senescence-associated secretory phenotype by SASP-RAP assay. | 2012 |
2 |
| 8 |
21168391 | Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines. | 2011 Mar 1 |
1 |
| 9 |
21903579 | p53-independent epigenetic repression of the p21(WAF1) gene in T-cell acute lymphoblastic leukemia. | 2011 Oct 28 |
3 |
| 10 |
20226587 | Potentiation of etoposide-induced apoptosis in HeLa cells by co-treatment with KG-135, a quality-controlled standardized ginsenoside formulation. | 2010 Aug 1 |
4 |
| 11 |
19421231 | Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells. | 2009 Sep |
2 |
| 12 |
17252195 | Cyclin-dependent protein kinase 2 activity is required for mitochondrial translocation of Bax and disruption of mitochondrial transmembrane potential during etoposide-induced apoptosis. | 2007 Jul |
6 |
| 13 |
17534580 | Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines. | 2007 Nov |
2 |
| 14 |
16513841 | Nuclear factor-kappaB dimer exchange promotes a p21(waf1/cip1) superinduction response in human T leukemic cells. | 2006 Feb |
1 |
| 15 |
16093994 | Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop. | 2005 Sep |
2 |
| 16 |
14660614 | The 31-kDa caspase-generated cleavage product of p130cas functions as a transcriptional repressor of E2A in apoptotic cells. | 2004 Feb 27 |
3 |
| 17 |
15191662 | [p33(ING1b) enhances chemosensitivity of osteosarcoma cell U2OS to etoposide]. | 2004 Jun |
2 |
| 18 |
12767922 | P21 response to DNA damage induced by genistein and etoposide in human lung cancer cells. | 2003 Jun 13 |
13 |
| 19 |
15314975 | Expression of p21 and bcl-2 proteins in paraffin-embedded preparations of non-small cell lung cancer in stage IIIA after Etoposide and Cisplatin induced chemotherapy. | 2003 |
1 |
| 20 |
11821415 | ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. | 2002 Apr 12 |
1 |
| 21 |
12429914 | The cyclin-dependent kinase inhibitor butyrolactone is a potent inhibitor of p21 (WAF1/CIP1 expression). | 2002 Jan |
1 |
| 22 |
12513833 | [p21(WAF1) transfection decreases sensitivity of K562 cells to VP-16]. | 2002 Feb |
2 |
| 23 |
12553001 | DNA topoisomerase II inhibitor, etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells. | 2002 Nov-Dec |
4 |
| 24 |
11423989 | p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. | 2001 Jun 7 |
1 |
| 25 |
11005251 | Identification and characterization of genes responsive to apoptosis: application of DNA chip technology and mRNA differential display. | 2000 Oct |
2 |
| 26 |
11045764 | Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines. | 2000 Oct |
1 |
| 27 |
11062729 | Concentration-dependent variable effects of etoposide on the cell cycle of CML cells. | 2000 Sep-Oct |
4 |
| 28 |
10023685 | Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop. | 1999 Jan 28 |
2 |
| 29 |
10218124 | Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1. | 1999 Jan-Feb |
1 |
| 30 |
9687575 | Involvement of the mismatch repair system in temozolomide-induced apoptosis. | 1998 Aug |
1 |
| 31 |
9739169 | DNA damage induces p21 protein expression by inhibiting ubiquitination in ML-1 cells. | 1998 Sep 16 |
4 |
| 32 |
9054953 | Potentiation of etoposide-induced apoptosis by staurosporine in human tumor cells is associated with events downstream of DNA-protein complex formation. | 1997 |
1 |
| 33 |
14646555 | Serum withdrawal and etoposide induce apoptosis in human lung carcinoma cell line A549 via distinct pathways. | 1997 |
2 |
| 34 |
8620501 | Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. | 1996 Apr 15 |
1 |
| 35 |
7970699 | Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. | 1994 Dec |
4 |